ID   ZN645_HUMAN             Reviewed;         425 AA.
AC   Q8N7E2; A0AV29; A0AV31; E3SBK4; Q6DJY9;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   10-MAY-2017, entry version 112.
DE   RecName: Full=E3 ubiquitin-protein ligase ZNF645;
DE            EC=2.3.2.27;
DE   AltName: Full=RING-type E3 ubiquitin transferase ZNF645;
DE   AltName: Full=Zinc finger protein 645;
GN   Name=ZNF645;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND VARIANT GLU-166.
RC   TISSUE=Testis;
RX   PubMed=20657603; DOI=10.1038/aja.2010.54;
RA   Liu Y.Q., Bai G., Zhang H., Su D., Tao D.C., Yang Y., Ma Y.X.,
RA   Zhang S.Z.;
RT   "Human RING finger protein ZNF645 is a novel testis-specific E3
RT   ubiquitin ligase.";
RL   Asian J. Androl. 12:658-666(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-166.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND DOMAIN HYB.
RX   PubMed=22252131; DOI=10.1038/emboj.2011.496;
RA   Mukherjee M., Chow S.Y., Yusoff P., Seetharaman J., Ng C., Sinniah S.,
RA   Koh X.W., Asgar N.F., Li D., Yim D., Jackson R.A., Yew J., Qian J.,
RA   Iyu A., Lim Y.P., Zhou X., Sze S.K., Guy G.R., Sivaraman J.;
RT   "Structure of a novel phosphotyrosine-binding domain in Hakai that
RT   targets E-cadherin.";
RL   EMBO J. 31:1308-1319(2012).
CC   -!- FUNCTION: E3 ubiquitin ligase catalyzing the covalent attachment
CC       of ubiquitin moieties onto substrate proteins. May operate on
CC       tyrosine-phosphorylated SRC substrates.
CC       {ECO:0000269|PubMed:22252131}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20657603}.
CC       Note=Localized over the postacrosomal perinuclear theca region and
CC       the entire length of sperm tail.
CC   -!- TISSUE SPECIFICITY: Exclusively expressed in testis and sperm,
CC       including spermatocytes, round and elongated spermatids, and
CC       Leydig cells. {ECO:0000269|PubMed:20657603}.
CC   -!- DOMAIN: The HYB domain forms a phosphotyrosine-binding pocket upon
CC       dimerization, and mediates as well the recognition of its flanking
CC       acidic amino acids. {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ355336; ADI56589.1; -; mRNA.
DR   EMBL; AK098601; BAC05348.1; -; mRNA.
DR   EMBL; BX293560; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC074910; AAH74910.1; -; mRNA.
DR   EMBL; BC126190; AAI26191.1; -; mRNA.
DR   EMBL; BC126192; AAI26193.1; -; mRNA.
DR   CCDS; CCDS14205.1; -.
DR   RefSeq; NP_689790.1; NM_152577.3.
DR   UniGene; Hs.132485; -.
DR   ProteinModelPortal; Q8N7E2; -.
DR   SMR; Q8N7E2; -.
DR   BioGrid; 127688; 6.
DR   IntAct; Q8N7E2; 7.
DR   STRING; 9606.ENSP00000323348; -.
DR   iPTMnet; Q8N7E2; -.
DR   PhosphoSitePlus; Q8N7E2; -.
DR   BioMuta; ZNF645; -.
DR   DMDM; 74759980; -.
DR   PaxDb; Q8N7E2; -.
DR   PeptideAtlas; Q8N7E2; -.
DR   PRIDE; Q8N7E2; -.
DR   DNASU; 158506; -.
DR   Ensembl; ENST00000323684; ENSP00000323348; ENSG00000175809.
DR   GeneID; 158506; -.
DR   KEGG; hsa:158506; -.
DR   UCSC; uc004dai.3; human.
DR   CTD; 158506; -.
DR   DisGeNET; 158506; -.
DR   GeneCards; ZNF645; -.
DR   HGNC; HGNC:26371; ZNF645.
DR   neXtProt; NX_Q8N7E2; -.
DR   OpenTargets; ENSG00000175809; -.
DR   PharmGKB; PA134934025; -.
DR   eggNOG; KOG2932; Eukaryota.
DR   eggNOG; ENOG410XQ6S; LUCA.
DR   GeneTree; ENSGT00510000047522; -.
DR   HOGENOM; HOG000082498; -.
DR   HOVERGEN; HBG057723; -.
DR   InParanoid; Q8N7E2; -.
DR   KO; K15714; -.
DR   OMA; PQFTENQ; -.
DR   OrthoDB; EOG091G0AJH; -.
DR   PhylomeDB; Q8N7E2; -.
DR   TreeFam; TF332910; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   GenomeRNAi; 158506; -.
DR   PRO; PR:Q8N7E2; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000175809; -.
DR   CleanEx; HS_ZNF645; -.
DR   Genevisible; Q8N7E2; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030155; P:regulation of cell adhesion; IBA:GO_Central.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Cytoplasm; Metal-binding; Polymorphism;
KW   Reference proteome; Transferase; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    425       E3 ubiquitin-protein ligase ZNF645.
FT                                /FTId=PRO_0000056316.
FT   ZN_FING      57     97       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     112    138       C2H2-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   REGION       96    154       HYB domain.
FT   COMPBIAS    254    343       Pro-rich.
FT   VARIANT     166    166       D -> E (in dbSNP:rs5951426).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:20657603}.
FT                                /FTId=VAR_030340.
FT   VARIANT     287    287       S -> F (in dbSNP:rs12860105).
FT                                /FTId=VAR_030341.
FT   CONFLICT    267    267       P -> L (in Ref. 1; ADI56589).
FT                                {ECO:0000305}.
FT   CONFLICT    411    411       H -> Q (in Ref. 1; ADI56589).
FT                                {ECO:0000305}.
SQ   SEQUENCE   425 AA;  48785 MW;  873C2802514CD9E5 CRC64;
     MNKMPAGEQE CEYNKEGKYY SKGVKLVRKK KKIPGYRWGD IKINIIGEKD DLPIHFCDKC
     DLPIKIYGRI IPCKHAFCYH CANLYDKVGY KVCPRCRYPV LRIEAHKRGS VFMCSIVQQC
     KRTYLSQKSL QAHIKRRHKR ARKQVTSASL EKVRPHIAPP QTEISDIPKR LQDRDHLSYI
     PPEQHTMVSL PSVQHMLQEQ HNQPHKDIQA PPPELSLSLP FPIQWETVSI FTRKHGNLTV
     DHIQNNSDSG AKKPTPPDYY PECQSQPAVS SPHHIIPQKQ HYAPPPSPSS PVNHQMPYPP
     QDVVTPNSVR SQVPALTTTY DPSSGYIIVK VPPDMNSPPL RAPQSQNGNP SASEFASHHY
     NLNILPQFTE NQETLSPQFT QTDAMDHRRW PAWKRLSPCP PTRSPPPSTL HGRSHHSHQR
     RHRRY
//
